DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Prilocaine hydrochlorideis the generic ingredient in four branded drugs marketed by Astrazeneca, Dentsply Pharm, and Septodont Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.
There are eight drug master file entries for prilocaine hydrochloride. One supplier is listed for this compound.
Recent Clinical Trials for prilocaine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
|Stanford University||Phase 3|
|Tehran University of Medical Sciences||Phase 3|
|Guy's and St Thomas' NHS Foundation Trust||Phase 4|
Pharmacology for prilocaine hydrochloride
|Drug Class||Amide Local Anesthetic |
|Physiological Effect||Local Anesthesia |
Medical Subject Heading (MeSH) Categories for prilocaine hydrochloride
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Dentsply Pharm||CITANEST PLAIN DENTAL||prilocaine hydrochloride||INJECTABLE;INJECTION||021382-001||Approved Prior to Jan 1, 1982||DISCN||Yes||No||Start Trial||Start Trial||Start Trial|
|Astrazeneca||CITANEST PLAIN||prilocaine hydrochloride||INJECTABLE;INJECTION||014763-007||Approved Prior to Jan 1, 1982||DISCN||Yes||No||Start Trial||Start Trial||Start Trial|
|Astrazeneca||CITANEST||prilocaine hydrochloride||INJECTABLE;INJECTION||014763-005||Approved Prior to Jan 1, 1982||DISCN||Yes||No||Start Trial||Start Trial||Start Trial|
|Astrazeneca||CITANEST||prilocaine hydrochloride||INJECTABLE;INJECTION||014763-003||Approved Prior to Jan 1, 1982||DISCN||Yes||No||Start Trial||Start Trial||Start Trial|
|Septodont Inc||PRILOCAINE HYDROCHLORIDE||prilocaine hydrochloride||INJECTABLE;INJECTION||079235-001||Sep 29, 2010||RX||No||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.